共 626 条
- [51] Long AA(2017)Chemotherapy in mastocytosis: administration issues, hypersensitivity, and rapid drug desensitization J Investig Allergol Clin Immunol 27 315-525
- [52] Banerji A(2012)Definitions, criteria and global classification of mast cell disorders with special reference to mast cell activation syndromes: a consensus proposal Int Arch Allergy Immunol. 157 215-376
- [53] Madrigal-Burgaleta R(2018)Hereditary alpha tryptasemia: genotyping and associated clinical features Immunol Allergy Clin North Am. 38 483-56
- [54] Berges-Gimeno MP(2018)Patient perceptions in mast cell disorders Immunol Allergy Clin North Am. 38 505-2267
- [55] Angel-Pereira D(2004)Clinical features and severity grading of anaphylaxis J Allergy Clin Immunol. 114 371-18
- [56] Ferreiro-Monteagudo R(2019)Breakthrough reactions during rapid drug desensitization: clinical outcomes and risk factors Ann Allergy Asthma Immunol. 123 48-165
- [57] Guillen-Ponce C(2005)Allergic-type reactions to oxaliplatin: retrospective analysis of 42 patients Eur J Cancer. 41 2262-1648
- [58] Pueyo C(2005)Carboplatin hypersensitivity Int J Gynecol Cancer. 15 13-115
- [59] Gomez de Salazar E(2007)The dilemma of carboplatin-associated hypersensitivity reactions in ovarian cancer management Gynecol Oncol. 107 163-807
- [60] Alvarez-Cuesta E(2018)Incidence and risk of oxaliplatin-induced hypersensitivity in patients with asymptomatic prior exposure: a prospective observational study J Allergy Clin Immunol Pract. 6 1642-571